Business1 Min Read SidonJune 10, 2025 Orbimed to sell 2.27% ownership in Marksans Pharma through a ₹256.8 crore block transaction. Global healthcare investment firm, OrbiMed Asia IV Mauritius FVCI Ltd, announced on Tuesday (June 10) a block trade to divest 2.27% of its…
